Literature DB >> 7586866

Supine and prone SPECT Tc-99m MIBI myocardial perfusion imaging for dipyridamole studies.

R Lisbona1, L Dinh, V Derbekyan, J A Novales-Diaz.   

Abstract

Aartifactual inferior wall defects of perfusion are a source of frequent concern during TI-201 exercise stress redistribution SPECT imaging in the supine position. These artifactual changes also affect Tc-99m sestamibi dipyridamole myocardial perfusion studies with supine SPECT yielding a specificity of only 58% for right coronary artery (RCA) disease. Complementary SPECT prone imaging will enhance this specificity for inferior wall abnormalities to 79% (P < 0.05) and is recommended for more accurate assessment of RCA stenosis, whether the patient challenge is pharmacological or by exercise.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586866     DOI: 10.1097/00003072-199508000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  The use of prone imaging on acute resting gated myocardial perfusion imaging with Tc-99m sestamibi.

Authors:  Benjamin A Lowenstein; Roger Pezzuti; Mylan C Cohen
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

2.  A second look with prone SPECT myocardial perfusion imaging reduces the need for angiography in patients at low risk for cardiac death or MI.

Authors:  Nicole E Worden; Paul D Lindower; Trudy L Burns; Kanu Chatterjee; Robert M Weiss
Journal:  J Nucl Cardiol       Date:  2014-07-01       Impact factor: 5.952

3.  Disappearance of myocardial perfusion defects on prone SPECT imaging: comparison with cardiac magnetic resonance imaging in patients without established coronary artery disease.

Authors:  Bo Hedén; Eva Persson; Marcus Carlsson; Olle Pahlm; Håkan Arheden
Journal:  BMC Med Imaging       Date:  2009-08-10       Impact factor: 1.930

4.  The Benefits of Prone SPECT Myocardial Perfusion Imaging in Reducing Both Artifact Defects and Patient Radiation Exposure.

Authors:  Maria Stathaki; Sophia Koukouraki; Emmanouela Papadaki; Angeliki Tsaroucha; Nikolaos Karkavitsas
Journal:  Arq Bras Cardiol       Date:  2015-09-25       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.